Skip to main content

Clarusvisus/Getty Images/iStockphoto

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Emerald Health Therapeutics, Inc. (EMH-X) says it has completed a letter of intent to form a joint venture with DMG Blockchain Solutions Inc. The JV will be named CannaChain Technologies and will develop a blockchain-based supply chain management system and e-commerce marketplace for the legal cannabis industry.

"CannaChain's supply chain management system platform will aim to provide total transparency and assurances for end consumers about where a cannabis product came from and regarding an array of related attributes," the company stated.

Story continues below advertisement

It said the platform will also assist in ensuring adherence to Health Canada reporting requirements.

**

Cannabis Wheaton Income Corp. (CBW-X) says it has entered into a "binding strategic alliance" and streaming agreement with IDP Group Inc. and HMT Solutions Inc. The agreement sees IDP, via a newly formed subsidiary, become a "significant streaming partner to the company," and the newest participant in the Wheaton Licensing Program.

IDP plans to operate out of its former Nestle Canada plant in Chesterville, Ont.

"The partnership with IDP is a fantastic addition to the Cannabis Wheaton platform as Hamed and the team bring years of complementary skills and technology to this project. We also look forward to implementing their proprietary vertical cultivation system and custom-made fabricated LED lighting systems that we believe can set new standards for yields per square foot and operating cash costs per gram for indoor cultivation. We believe this to be an exciting and an accretive deal for both parties," Chuck Rifici, CEO of Cannabis Wheaton, stated in a release. 

Separately, the company issued a statement after markets closed on Thursday regarding recent market activity in its common stock traded on the OTCQB marketplace. The company said it became aware of "certain promotional activity" on its securities on Jan. 22, "encouraging investors to purchase the company's common stock.

"Until being informed by OTC Markets of the promotional material, the company was unaware of the promotional activity and is unaware of the full nature of the promotional activity and the extent of the dissemination. After due inquiry, the company does not believe that the promotion resulted in any increased trading activity in the company stock."

**

Nexus REIT (NXR.UN-T) announced changes to its co-CEO structure.

It said Kelly Hanczyk, the former CEO of Edgefront REIT and co-CEO of Nexus REIT has become the CEO Nexus REIT. Jean Teasdale, former CEO of Nobel REIT and co-CEO of Nexus REIT will be leaving Nexus REIT to head up a private real estate business of RFA Capital Partners.

Pending the completion of this transition, Jean will be acting in a COO role with a continued focus on the leasing and property management of the Nexus portfolio, the company said.

**

TerraVest Capital Inc. (TVK-T) says it has acquired Maxfield Group Inc., a private Alberta-based transportation equipment company, for $21-million, subject to a working capital adjustment. Maxfield handles storage and transportation equipment for the propane, anhydrous ammonia and oil and gas markets.

Story continues below advertisement

"Maxfield is a natural extension of TerraVest's existing operations and solidifies the company as a leading manufacturer of equipment for the propane and anhydrous ammonia markets across Canada," stated  TerraVest CEO Dustin Haw.

**

Invictus MD Strategies Corp. (IMH-X) says it has signed the definitive agreement to make its further strategic investment in AB Laboratories Inc. to 50 per cent, up from 33.3 per cent. It also announced the sale of its first 120 kg of dried flower from AB Laboratories Inc. to Canopy Growth Corp. (WEED-T).

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Comments are closed

We have closed comments on this story for legal reasons or for abuse. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Cannabis pro newsletter